Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004741 |
---|---|
Receipt number | R000005386 |
Scientific Title | A phase 2 study of weekly Paclitaxel plus Gemcitabine Combination Chemotherapy in Patients with advanced or metastatic Breast Cancer |
Date of disclosure of the study information | 2010/12/17 |
Last modified on | 2018/07/13 10:22:59 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/12/17 02:48:06 | ||
2 | Update | 2012/01/18 16:54:13 | Organization Division name Address Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2012/01/18 17:02:21 | Address |
|
4 | Update | 2012/12/17 16:46:49 | Recruitment status |
|
5 | Update | 2013/12/18 13:51:24 | Email Address1 |
|
6 | Update | 2013/12/18 13:53:34 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
7 | Update | 2018/07/13 10:22:59 | Division name Division name Division name Division name Name of primary person or sponsor Organization Organization Email1 |